Skip to content

Combining MyoCI With Memory Reactivation to Improve Motor Recovery After Stroke

Combining MyoCI With Memory Reactivation to Improve Motor Recovery After Stroke

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04312269
Enrollment
70
Registered
2020-03-18
Start date
2020-02-25
Completion date
2027-01-30
Last updated
2026-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Keywords

Sleep

Brief summary

This study will examine the combination of myoelectric computer interface (MyoCI) training with targeted memory reactivation (TMR) in chronic stroke survivors. The study aims to determine whether this training-plus-sleep combination will generalize to improve arm motor function over an extended training protocol in stroke survivors.

Interventions

Targeted memory reactivation (TMR) refers to the process of playing audio cues associated with specific learned material quietly during sleep in order to strengthen consolidation of specific memories during sleep.

Sponsors

Northwestern University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Masking description

Outcomes assessors and participant are blinded to groups.

Eligibility

Sex/Gender
ALL
Age
21 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

* Age at enrollment is 21 or older * Hemiparesis from first ever stroke affecting arm movement at least 6 months prior to screening * Severe to moderate motor impairment (FMA-UE of 7-40) * At least some voluntary shoulder and elbow muscle activation

Exclusion criteria

* Inability to follow instructions of the MyoCI task * Visual impairment (such as hemianopia) preventing full view of screen * Anesthesia or neglect in the affected arm, or visual hemineglect (score of 2 on the NIH Stroke Scale Extinction and Inattention subtest) * Participation in another study on the affected arm within 6 weeks of enrollment or any pharmacological study * Inability to understand or follow commands in English due to aphasia or other reason * Diffuse or multifocal infarcts in both hemispheres * Substantial arm pain preventing participation for 90 minutes a day * Spasticity treatment (pharmacological or Botox) within last 3 months * Ferromagnetic implants that are MRI incompatible

Design outcomes

Primary

MeasureTime frameDescription
Wolf Motor Function Test (WMFT)change from baseline at 6 weeksThe WMFT evaluates upper extremity function on a continuous scale. It measures the time it takes to perform 15 different tasks, with a time limit of 120 s per task.

Secondary

MeasureTime frameDescription
Fugl-Meyer Assessment of Upper Extremity (UE) Motor Functionchange from baseline at 6 weeksThe FMA-UE is a measure of impairment. Maximum score is 66 on the motor function portion. Items are scored on a 3-point ordinal scale.
Motor Activity Log (MAL)change from baseline at 6 weeksThe MAL is a validated measure of home-based arm function, both quantity and quality of use in 30 different activities of daily living.
Modified Ashworth Scalechange from baseline at 6 weeksThe Modified Ashworth Scale is a measure of spasticity, which is graded on a scale of 0-4 per joint tested.

Countries

United States

Contacts

CONTACTMarc W Slutzky, MD/PhD
mslutzky@northwestern.edu312-503-4653
PRINCIPAL_INVESTIGATORMarc W Slutzky, MD/PhD

Northwestern University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 28, 2026